Company ProfilePremium

CNNC International Limited

Company Profile Analysis

Ticker: 2302.HK中核國際有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
CNNC International Limited - Company showcase

Year Founded & Workforce

2002

39 Employees

CNNC International Limited logo

CNNC International Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

CNNC International Limited Overview

CNNC International is the sole Hong Kong-listed, offshore uranium platform of China National Nuclear Corporation, China's state-owned nuclear champion. The company is, in substance, an asset-light natural uranium (U3O8) trading house rather than a miner: in FY2025 it sold approximately 8.77 million pounds of natural uranium and generated HK$2.49bn of revenue, essentially all from its "Trading of Mineral Properties" segment. Its commercial moat is structural rather than technological — under successive framework agreements with its intermediate parent CNUC, it acts as the exclusive offshore supplier of non-Asian, non-African uranium to the CNUC Group, as the CNUC Group's procurement agent, and as exclusive ex-China distributor for the Rössing mine in Namibia. Legacy upstream assets (a 37.2% stake in Niger's idle Azelik/Somina mine and an exploration project in Mongolia with expired licences) are written down. With HK$733m of cash, no borrowings and 39 staff, it is a cash-rich, thin-margin, policy-anchored trading vehicle whose earnings are highly sensitive to spot-market volatility and parent-group delivery schedules.


Company's own description (latest filings)

The company describes itself (H1 2026 interim results, "Business Overview") as continuing "its business of trading uranium products in its normal and usual course of business", focusing on and developing its uranium products trading business while "actively seeking high-quality uranium resources projects to complement the development of the Parent Group". Its stated strategic pursuit is to become the CNUC Group's major platform for overseas uranium resources exploration, development and trading, and to be "designated as the procurement arm of the CNUC Group in the international uranium market" (H1 2026 interim, Future Strategies).

The two reportable segments under HKFRS 8 are:

Trading of mineral properties: trading of uranium and commission income from uranium procurement services;

Exploration and selling of mineral properties: exploration and selling of uranium (currently pre-revenue; legacy Mongolia project).

Business model

CNNC International makes money in three ways, all within the trading segment:

  1. Principal trading (gross revenue recognition). The group buys natural uranium (U3O8) from producers, traders and inventory holders — principal suppliers are located in the United States, Europe/Canada, Kazakhstan and Hong Kong (Morningstar/extraETF company descriptions) — and on-sells it either to (a) independent third parties (utilities, traders, financial buyers) or (b) the CNNC Parent Group under the "Uranium Supply Transaction" continuing connected transaction (CCT). The group takes price and basis risk on these trades and earns the spread.

  2. Agency procurement (net commission). Under the "Uranium Agency Transaction", the group procures uranium in the market to meet sporadic CNUC Group demand and earns a commission recognised on a net basis.

  3. Distribution for Rössing (net commission). Under the "Uranium Purchase Transaction", the group acts as exclusive authorised distributor for uranium produced by the Rössing Uranium Mine in Namibia (68.62% indirectly owned by the CNUC Group) for on-sale to customers outside the PRC, earning commissions without assuming pricing risk.

Revenue mix (derived from FY2024 Final Results Note 3 and Gelonghui FY2025 coverage):

FY2025 commission income = HK$30.994m (Uranium Purchase Transaction / Rössing) + HK$13.657m (Uranium Agency Transaction) per Gelonghui's summary of the FY2025 results; principal trading derived as the residual. In product/service terms the mix is ~98% product sales, ~2% service/commission; there is no subscription or licensing revenue.

Value-chain position

The company sits in the mid-stream "physical market intermediary" link of the nuclear fuel cycle: between uranium miners (Kazatomprom, Cameco, Orano, Rössing) and the conversion/enrichment/fuel-fabrication chain whose ultimate customers are nuclear utilities. Material is typically transferred by book-transfer at conversion facilities (FY2024 MD&A references storage fees at "designated natural uranium conversion facilities"). The company does not convert, enrich or fabricate fuel, and has no producing mine.

Customer types and end-markets

Parent Group (CNNC/CNUC): the anchor customer for supply and agency transactions — destined for China's nuclear fleet (60 commercial units, 63.69 GW in operation, per the China Nuclear Energy Development Report 2026 as cited in the H1 2026 interim).

Independent third parties: international utilities and traders in the UK, Netherlands, Japan, the US and Canada (FY2023–FY2025 geographic disclosures).

Rössing Uranium Limited: a related-party principal for whom the company distributes ex-China.

Independent characterisation

CNNC International is best characterised as a captive, state-backed uranium trading desk wrapped in a listed shell. Its earnings power is a function of (i) the volume of CCT business allocated by its parent (delivery schedules are back-half weighted — H1 2026 interim), (ii) management's appetite for third-party spot risk (curtailed sharply in H1 2026), and (iii) interest income on a large cash balance. Gross margins (10.9% in FY2025) are high for a pure trading business — sector peer CGN Mining's trading arm earned a 1.0% group gross margin in FY2025 — reflecting opportunistic spot positioning in 2023–2025 rather than structural pricing power. Legacy upstream assets contribute nothing and carry residual political/legal risk.

Strategy

Stated strategy (themes from FY2024 annual results and H1 2026 interim, "Future Strategies")

  1. Focus resources on uranium products trading, while actively seeking high-quality uranium resources projects "with intended focus on in-production projects" to complement the Parent Group.

  2. Leverage the Parent Group as a "strategic alliance that produces synergistic effects", cementing the group's position in uranium trading.

  3. Become the CNUC Group's major overseas platform in uranium exploration, development and trading, and its designated international procurement arm.

  4. Enlarge business scale by participating in international market bidding, increasing market exposure, exploring financing channels and developing new trading counterparties.

  5. Resolve legacy assets: Mongolian licence expiry dispute; Somina restart plan with the Nigerien government and co-shareholders.

  6. Long-term diversification leveraging CNNC's nuclear strengths "to develop projects with reasonable returns", subject to financial health and market dynamics.

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

DateInitiativeDetailSource
Oct–Nov 2024Non-core disposalSale of CNNC International (HK) incl. 7.55% CNNC Leasing to CNNCTM for HK$162.4m to reduce exposure to non-strategic sectors and redeploy into uraniumFY2024 final results
Jul 2024 / Aug 2025Parent funding lineUS$50m revolving facility from CNNCTM (Jul 2024); Aug 2025 announcement of up to US$50m for the uranium trading businessFY2024 final results; MarketScreener (21 Aug 2025)
31 Dec 2025 – 10 Mar 20262026 Framework Agreement with CNUCRenews exclusive supplier, agent and exclusive ex-PRC Rössing distributor roles; caps for FY2026–FY2027 approved by independent shareholdersH1 2026 interim
Q1–Q2 2026Risk-management pivotReduced third-party spot trading; emphasis on no-price-risk Rössing distributionH1 2026 interim
H1 2026ESG consultancyProfessional ESG consultation cited as a driver of higher admin costsH1 2026 interim
24 Jun 2026New bank facilityUp to US$30m uncommitted general banking facility for purchasing natural uranium; each drawdown repayable within 180 days; conditions precedent satisfied (announced 3 Jul 2026, including a Rule 13.18 specific-performance-covenant disclosure)Hstong/company announcement; ETNet
H1 2026Manpower expansionHeadcount 34 → 39H1 2026 interim

Medium-term targets / guidance

FY2026 volume target: "not less than approximately four million pounds" in H2 2026 and full-year uranium trading volume "targeted at least approximately five million pounds" (H1 2026 interim). This is the only quantitative guidance.

  • No medium-term revenue, margin, ROE or dividend targets are published. No cost programme with targets has been disclosed.

Products & Services

The company's "portfolio" is narrow; each line is catalogued below.

Trading of mineral properties segment

(a) Natural uranium (U3O8) — principal sales to the Parent Group ("Uranium Supply Transaction")

Description: Exclusive supply to the CNUC Group of natural uranium purchased from sellers other than those based in Asia and Africa (2024 and 2026 Framework Agreements).

Specifications: Natural uranium concentrate (U3O8), delivered by book transfer; volumes: 3.32m lb in FY2024; ~720 lb in H1 2026 (deliveries scheduled mainly in H2 2026).

Target customer: CNUC Group (for China's reactor fleet).

Latest version: 2026 Framework Agreement (approved 10 Mar 2026; caps for FY2026–FY2027).

Pricing: Market-referenced; annual caps approved by independent shareholders (cap values n/d in sources reviewed).

(b) Natural uranium — principal sales to independent third parties

Description: Spot and term trades with utilities, traders and financial participants internationally.

Volumes: ~0.20m lb in FY2024 (as reported) and in H1 2026; the majority of H1 2025 revenue (~HK$582m of HK$592m) came from third-party natural uranium sales.

Target customers: Counterparties in PRC/HK, UK, Netherlands, Japan, US, Canada.

Pricing: Market (spot/term), group bears price risk.

(c) Uranium Agency Transaction — procurement agency for CNUC Group (commission)

Description: Acts as agent to source uranium in the market for sporadic CNUC demand.

Volumes/economics: 0.75m lb in FY2024 (commission ~HK$5.8m); FY2025 commission ~HK$13.7m; H1 2026 ~230 lb.

Pricing: Commission, recognised net.

(d) Uranium Purchase Transaction — exclusive ex-PRC distributor for Rössing Uranium Mine (commission)

Description: Exclusive authorised distributor of Rössing (Namibia) output for on-sale to third parties worldwide except the PRC; no pricing risk assumed.

Volumes/economics: 1.50m lb facilitated in FY2024 (commission ~HK$18.8m); FY2025 commission ~HK$31.0m; H1 2026 0.56m lb facilitated.

Pricing: Commission.

Exploration and selling of mineral properties segment

(e) Mongolian uranium exploration project (originally Western Prospector's Gurvanbulag project)

Description: Uranium project in eastern Mongolia; Gurvanbulag had M&I resources of 4.28 Mt at 0.189% U3O8 plus 0.795 Mt inferred at 0.126% (Western Prospector estimate cited by Northern Miner, 2009).

Status: Exploration licences expired; company in discussion with Mongolian authorities "to resolve the expiry issue" (H1 2026 interim). Carrying value of exploration and evaluation assets: nil since FY2019 impairment.

(f) Somina / Azelik mine, Niger (associate, 37.2%)

Description: Uranium mine operated by Somina; "still facing serious cash flow problems and is unable to resume production in the short term" (H1 2026 interim); the group is discussing a preliminary restart plan with other shareholders and the Nigerien government.

Status: No production; no equity income.

Discontinued/historical lines (for completeness)

  • Electronics products trading (LCDs, flash drives, memory cards) — commenced 2018, last trade 2020; inventory write-down of ~HK$52m in FY2020 triggered the 2021–2022 audit investigation.

  • Investment in CNNC Financial Leasing (7.55%) — disposed November 2024.

  • Some data vendors also list "electricity transmission services" in the company description; no such revenue appears in FY2022–H1 2026 filings (not corroborated).

Financial Narrative

Sources: ETNet financial summary (FY2022–H1 2026), FY2024/FY2023/FY2022 Final Results announcements, FY2022 profit alert (FY2021 continuing revenue and gross profit), FY2020 unaudited results, H1 2026 interim, Gelonghui (FY2025 cash flow, volumes), TipRanks (FY2021–FY2022 cash flow). FY2021 revenue and gross profit are for continuing operations.

Income statement: notes and sources

Notes: FY2021 cost of sales derived as revenue less gross profit (continuing). FY2021–FY2022 EPS derived (net profit ÷ 489.168m shares). Operating income is not presented as a line item under the company's HKFRS income statement format; EBITDA is derived only where finance costs and D&A are disclosed (FY2023: finance 14.044, D&A 0.270; FY2024: finance 21.729, D&A 1.784). FY2024 EBITDA includes the HK$23.4m disposal gain and HK$32.0m associate share; "core" FY2024 EBITDA excluding these ≈ HK$194.7m (derived).

Margins and growth (derived)

Revenue CAGR FY2021–FY2025 (derived): ~72.6% (HK$280.6m → HK$2,489.9m). Revenue CAGR FY2022–FY2025: ~40.1%. FY2020 revenue was ~HK$663m and FY2019 ~HK$3.17bn (TipRanks), so the long-run series is distorted by the exited electronics business.

Balance sheet

Sources: FY2022 final results (FY2021–FY2022 totals, net assets, associates, net current assets); FY2023 and FY2024 final results; H1 2026 interim (31 Dec 2025 comparatives). FY2021–FY2022 cash from TipRanks "end cash position". Total liabilities derived as total assets less net assets.

H1 2026 snapshot (30 Jun 2026): total assets HK$981.2m; cash HK$732.6m; trade receivables HK$201.3m (0–30 days); amount due from immediate holding company HK$37.0m; total liabilities HK$106.7m; no borrowings; equity HK$874.5m; gearing (total liabilities/total assets) 0.11.

Cash flow: notes and sources

Sources: TipRanks (FY2021–FY2022 OCF/FCF), FY2024 final results (FY2023–FY2024 OCF, capex, net cash inflow), Gelonghui summary of FY2025 results (OCF ~HK$288m, +105.7%). FY2024 net cash inflow included HK$161.7m disposal proceeds and HK$115.2m repayment of a fellow-subsidiary balance. H1 2026 net cash outflow was HK$175.0m (cash used in uranium trading / working capital), vs inflow of HK$179.1m in H1 2025.

Ratios (derived unless stated)

FY2023 and FY2024 ROE of 23.1% and 28.9% match the company's own disclosure (FY2024 MD&A). ROIC: with no interest-bearing debt in FY2024–FY2025 and most capital held as cash, ROIC on operating invested capital (equity less cash) is not meaningful (FY2025 operating invested capital ≈ HK$-38m, derived). Net debt/EBITDA: net cash in FY2024–FY2025. Cash conversion cycle: not computable reliably — trade receivables and payables are both on 5–30 day terms and inventory is negligible at most period-ends (FY2023 was an exception with HK$290m of uranium inventory).

Commentary on trends, inflections and drivers

FY2021 — trough after strategic exit. With the electronics business abandoned and the shares suspended, FY2021 continuing revenue fell to HK$280.6m with a gross profit of only HK$20.6m; net profit of HK$2.4m was rescued by associate income (CNNC Leasing). This is the base from which the uranium-trading rebuild started.

FY2022 — the CNUC framework inflection. Revenue tripled to HK$905.7m and gross profit to HK$102.8m. The FY2022 profit alert attributes the increase to higher trading volume driven by an improving uranium market, upward price momentum and the execution of uranium trading transactions with China National Uranium Corporation under the 2022 framework (circular of 31 May 2022). Net profit reached HK$80.8m, of which HK$25.1m came from associates.

FY2023 — margin peak on spot spike. Revenue fell 35.9% to HK$581.0m, yet gross profit rose to HK$127.1m and gross margin to 21.9%, as the group benefited from the H2 2023 influx of financial buyers into the spot market (FY2024 MD&A). Finance costs of HK$14.0m reflected higher rates on trade financing. Uranium inventory of HK$290m was held at year-end, financed by trade payables of HK$304m.

FY2024 — volume and balance-sheet reset. Revenue rose 217% to HK$1.84bn on 5.77m lb (including facilitated volumes), as the group cleared the Parent Group's backlog carried over from 2023. Gross margin normalised to 12.7% because the 2023 spot-buyer windfall did not recur. Profit of HK$195.0m included two non-recurring items (HK$23.4m disposal gain, HK$32.0m associate share); management's own "core" uranium-trading profit was ~HK$140m (FY2025 profit alert). The CNNC Leasing disposal transformed the balance sheet: the HK$182m parent loan was extinguished and cash rose to HK$607m.

FY2025 — record scale, quality improvement. Revenue reached HK$2.49bn (+35.2%) on ~8.77m lb sold; gross profit rose 16.0% to HK$271.6m with gross margin at 10.9%. Reported net profit (HK$192.4m) was flat, but core trading profit rose ~38% versus the HK$140m FY2024 core figure. Operating cash flow more than doubled to ~HK$288m and year-end cash reached HK$907m with zero borrowings. Notable mix shift: UK and Netherlands customers contributed HK$342m and HK$306m respectively.

H1 2026 — deliberate de-risking. Revenue collapsed 76% to HK$142.1m as the board judged spot trading "overly burdensome" amid a Q1 2026 spike above US$101/lb and Middle East conflict; the group pivoted to riskless Rössing distribution. Net profit fell to HK$5.3m but was supported by HK$13.4m of bank interest income — interest now exceeds gross profit, underscoring the cash-rich, low-utilisation nature of the balance sheet. Management targets ≥4m lb in H2 2026 and ≥5m lb for FY2026 (vs ~8.77m lb in FY2025), implying a materially lower FY2026 revenue base.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts/services

Trading of mineral properties

Physical uranium trading desk (Hong Kong/PRC)

U3O8 principal sales to Parent Group and third parties; commission income from Uranium Agency and Uranium Purchase (Rössing) transactions

Exploration and selling of mineral properties

Mongolian uranium exploration project (licences expired/disputed); historically Somina-related activities

No revenue; carrying costs only

Segment revenue (HKD Mn)

Segment revenue (HKD Mn)FY2023FY2024FY2025

Trading of mineral properties

581.01,841.32,489.9

Exploration and selling of mineral properties

000

Total

581.01,841.32,489.9

Segment profit (HKD Mn)

Segment profit (HKD Mn)FY2023FY2024

Trading of mineral properties — segment profit

116.6209.3

Exploration and selling — segment loss

-6.0-6.2

Total segment profit

110.6203.1

Segment Margins & Growth (%) and Revenue by Segment (%)

MetricFY2023FY2024FY2025

Trading segment profit margin (%)

20.111.4—

Trading segment revenue growth YoY (%)

-35.9217.035.2

Trading segment share of revenue (%)

100100100

Segment Assets & Liabilities

Segment balance sheet (HKD Mn)FY2023FY2024FY2025

Trading segment assets

514.7630.7964.9

Exploration segment assets

6.03.59.0

Trading segment liabilities

310.3179.298.8

Exploration segment liabilities

22.319.621.6

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

280.6905.7581.01,841.32,489.9

Cost of sales (HKD Mn)

260.0802.9453.91,607.22,218.4

Gross profit (HKD Mn)

20.6102.8127.1234.2271.6

Share of results of associates (HKD Mn)

—25.132.232.00

Gain on disposal (HKD Mn)

—02.423.40

Finance costs (HKD Mn)

——14.021.7—

Profit before tax (HKD Mn)

—88.1123.1226.6229.9

Income tax (HKD Mn)

—7.216.831.637.5

Net profit attributable (HKD Mn)

2.480.8106.3195.0192.4

EBITDA — PBT + finance costs + D&A (HKD Mn)

——137.4250.1—

Basic & diluted EPS (HK cents)

0.4916.5321.739.939.3

Dividend per share (HK cents)

00000

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

7.311.321.912.710.9

Pre-tax margin (%)

—9.721.212.39.2

EBITDA margin (%)

——23.713.6—

Net margin (%)

0.98.918.310.67.7

Revenue growth YoY (%)

-57.7222.7-35.9217.035.2

Effective tax rate (%)

—8.213.613.916.3

Balance Sheet

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (HKD Mn)

592.7646.9990.9880.1996.8

Cash and cash equivalents (HKD Mn)

120.6130.7180.4607.0907.1

Interests in associates (HKD Mn)

456.1438.3412.700

Inventories (HKD Mn)

——291.71.30.9

Total liabilities (HKD Mn)

258.0255.3530.6206.2128.3

Interest-bearing debt — loan from immediate holding co. (HKD Mn)

——182.000

Short-term bank borrowings at year-end (HKD Mn)

———00

Net debt (HKD Mn; negative = net cash)

——1.6-607.0-907.1

Shareholders' equity (HKD Mn)

334.7391.6460.3673.9868.5

Goodwill & intangibles incl. E&E assets (HKD Mn)

00000

Net current assets / working capital (HKD Mn)

96.2135.0226.6670.5864.8

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (HKD Mn)

31.07.573.4140.0288.0

Capex — PP&E (HKD Mn)

——0.40.6—

Free cash flow (HKD Mn)

30.77.372.9139.3—

Dividends paid (HKD Mn)

00000

Share buybacks (HKD Mn)

00000

Net change in cash (HKD Mn)

——51.0427.6—

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE on closing equity (%)

0.720.623.128.922.2

ROA on closing assets (%)

0.412.510.722.219.3

Current ratio (x)

——1.664.287.77

Total liabilities / equity (x)

0.770.651.150.310.15

Gearing — total liabilities / total assets (x, company definition)

0.440.390.540.230.13

Interest coverage — (PBT + finance costs) / finance costs (x)

——9.811.4—

Asset turnover — revenue / average total assets (x)

—1.460.711.972.65

OCF / net profit (x)

12.960.090.690.721.50

Revenue by Region

Region (HKD Mn)FY2023FY2024FY2025

PRC incl. Hong Kong

455.21,704.61,769.0

United Kingdom

84.35.3342.0

Netherlands

03.1306.0

Japan

1.763.1—

United States

39.762.5—

Canada

02.7—

Other / not separately identified in sources reviewed

0072.9

Total

581.01,841.32,489.9

Revenue by Region (%) and Region Margins & Growth (%)

MetricFY2023FY2024FY2025

PRC share of revenue (%)

78.392.671.0

Non-PRC share of revenue (%)

21.77.429.0

PRC revenue growth YoY (%)

—274.53.8

Non-PRC revenue growth YoY (%)

—7.9427.6

Share Price History

DatePrice (HKD)Source

4 Nov 2024

1.80 (52-week range then 0.86–2.63)

Google Finance

3 Jun 2026

4.71 close (intraday high 4.95)

Securities Star via Hstong

18 Jun 2026

3.94

Fintel / Histock

6 Jul 2026

4.32

ETNet

9 Jul 2026

4.05

Securities Star via Hstong

17 Jul 2026

3.76

Histock

19 Aug 2026

~4.16 (implied from CCASS market value ÷ shares)

Lixinger

Valuation Snapshot

MultipleValueBasis

Market capitalisation

~HK$2.03bn

489.17m × HK$4.16

Enterprise value

~HK$1.30bn

Mkt cap − cash HK$732.6m (30 Jun 2026), no debt

P/E — FY2025

~10.6x

EPS HK$0.393

P/E — trailing 12m to Jun 2026

~10.9x

TTM EPS HK$0.3826 (39.3 − 2.12 + 1.08 cents)

P/B

~2.33x

Equity HK$874.5m (30 Jun 2026)

EV/Sales — FY2025

~0.52x

Revenue HK$2,489.9m

EV/Sales — TTM

~0.64x

TTM revenue HK$2,039.9m

Dividend yield

0%

No dividends

Capital Markets

MetricFY2021FY2022FY2023FY2024FY2025

Dividend per share (HK cents)

00000

Payout ratio (%)

00000

Analyst Conclusions

Management guidance

  • FY2026 uranium trading volume of at least ~5m lb, with ≥4m lb in H2 2026; Parent Group Uranium Supply deliveries primarily scheduled in H2 2026 (H1 2026 interim).

  • Management expects to increase third-party trading in H2 2026 as spot prices "have somewhat stabilized".

  • No revenue, profit or dividend guidance.

Consensus

No sell-side consensus estimates are available. On management's volume target, FY2026 volume would be ~43% below FY2025's ~8.77m lb, implying a materially lower revenue and profit year unless margins or mix improve markedly (analyst inference, not guidance).

Bull case

  1. Structural mandate + rising LT prices: exclusive CNUC supply and Rössing distribution through FY2027 coincide with LT uranium at ~US$95/lb, a 2008-level high, and China's 112-unit/125 GW pipeline.

  2. Cash optionality: HK$733m net cash is ~36% of market cap; deployment into an in-production asset, a buyback or an inaugural dividend could re-rate the stock.

  3. Demonstrated core-earnings growth: FY2025 core trading profit rose ~38% to ~HK$190m with OCF of ~HK$288m at ~10.6x P/E.

Bear case

  1. Earnings are episodic: H1 2026 net profit of HK$5.3m shows that when spot volatility rises, management withdraws and earnings collapse; FY2026 volume target is ~5m lb vs 8.77m lb.

  2. Capital is trapped: zero dividends for five-plus years despite record cash; minority shareholders bear controlling-shareholder conflict with no payout.

  3. Mandate concentration and policy risk: volumes depend on parent allocations, framework renewals (next by end-2027) and US–China trade measures (Section 232).

Catalysts and monitorables (next 12 months)

  • H2 2026 delivery execution vs the ≥4m lb target; FY2026 profit alert (expected ~Feb 2027) and FY2026 results (~Mar 2027).

  • Use of the US$30m bank facility and CNNCTM line (signals third-party trading appetite).

  • Any dividend declaration or buyback under the AGM mandate.

  • Spot/LT uranium prices, SPUT purchasing, US Section 232 tariff decisions.

  • Mongolia licence resolution and Somina restart plan.

  • Any acquisition of an in-production uranium asset.

  • Board changes following Wu Ge's re-designation; framework cap utilisation disclosures in the 2026 annual report.

Analyst verdict

CNNC International has completed a genuine transformation since its 2021–2022 suspension: it shed the failed electronics business and the CNNC Leasing stake, extinguished parent debt, and rebuilt a profitable uranium trading franchise anchored by shareholder-approved exclusivity with CNUC and Rössing. The FY2025 numbers — HK$2.49bn of revenue, ~HK$190m of core trading profit, ~HK$288m of operating cash flow and HK$907m of year-end cash against zero debt — describe a clean, cash-generative business trading at roughly 10–11x earnings and about 0.5x EV/Sales.

The difficulty is that this is a policy-shaped trading desk, not a compounding asset. Its volumes are set by the parent's procurement calendar and by management's tolerance for spot risk, which proved low when prices spiked in Q1 2026; H1 2026 profit fell to HK$5.3m, and bank interest now rivals gross profit. Management's FY2026 target of ~5m lb, well below 2025's ~8.77m lb, points to a year of lower earnings. Legacy upstream assets in Mongolia and Niger carry option value only, and the market has learned to ascribe little to it after more than a decade without resolution.

The investment case therefore rests less on operating momentum than on capital allocation. With cash equal to roughly a third of market capitalisation and a P/B of ~2.3x, the single most value-accretive step available to the board is to establish a payout policy or deploy cash into a producing asset at a sensible price; neither has been signalled. Until it is, the shares are likely to trade as a sentiment proxy for the uranium price with an earnings base that the parent can expand or contract at will. We would characterise the risk/reward as balanced with a negative near-term earnings skew: constructive on the medium-term uranium cycle and the durability of the CNUC mandate, cautious on FY2026 earnings and minority-shareholder returns. Key watchpoints: H2 volumes, capital return, and framework renewal beyond 2027.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure / notesCommitteesSource

Li Feng (李峰)

Chairman, Non-executive Director

Appointed 1 Dec 2025, succeeding Wang Cheng

Chair, Nomination

H1 2026 interim; MarketScreener

Zhang Yi (張義)

Executive Director & CEO

CEO since at least March 2021; born 1984 (S&P data)

Remuneration, Nomination

Board notices 2021–2026; Yahoo Finance

Wu Ge (吳戈)

Executive Director

On board since at least 2021 as NED; re-designated executive director 6 Aug 2026 and left Audit Committee

Remuneration

H1 2026 interim

Sun Ruofan (孫若凡)

Non-executive Director

On board since at least March 2024

—

Board notices

Cui Liguo (崔利國)

Independent NED

On board since at least 2021

Chair, Remuneration; Audit; Nomination

H1 2026 interim

Chan Yee Hoi (陳以海)

Independent NED

On board since at least 2021

Chair, Audit; Remuneration; Nomination

H1 2026 interim

Liu Yajie (劉亞潔)

Independent NED

Joined 2024 (replacing Zhang Lei)

Audit; Remuneration; Nomination

Board notices 2024–2025

Directors' Remuneration

Item (HKD K)FY2023FY2024

Directors' emoluments (total)

1,8802,457

Total staff costs (incl. directors)

20,51129,359

Board & Management Changes

DateChange

2023 (by Mar 2023)

Wang Cheng replaces Zhong Jie as chairman

2023–2024

Sun Ruofan joins as NED; Liu Yajie replaces Zhang Lei as INED

3 Dec 2024

Company secretary changed (Li Philip Sau Yan → Xu Ling)

1 Dec 2025

Wang Cheng retires; Li Feng appointed chairman, NED and Nomination Committee chair

6 Aug 2026

Wu Ge re-designated from NED to executive director; ceases Audit Committee membership

Shareholding by CCASS Participant

CCASS participant (custodian)Shares (m)% of issued

CCB International Securities (holds the parent block)

326.066.73

UOB Kay Hian (Hong Kong)

47.79.76

HSBC (Hongkong and Shanghai Banking Corp)

19.33.96

Hang Seng Bank

7.51.54

Hang Seng Securities

7.41.52

Bank of China (Hong Kong)

7.31.49

Competitive Landscape

Key Competitors

CompetitorTypeRelevance to CNNC InternationalPositioning

CGN Mining (1164.HK)

HK-listed uranium trader/producer (China General Nuclear)

Closest listed peer: offshore uranium platform of China's #2 nuclear group

Larger revenue (HK$6.87bn FY2025), equity production via Semizbay-U and Ortalyk (Kazakhstan); thinner trading margins

China National Uranium Corp (CNUC)

Sister company

Handles Asia/Africa-sourced supply directly; defines CNNC Intl's mandate boundary

Captive partner more than competitor

Kazatomprom

World's largest producer; sells directly and via trading subsidiaries

Competes for utility offtake; major supplier

Low-cost ISL producer; sulfuric-acid constraints

Cameco

Producer/trader (Canada)

Competes for Western utility contracts; trades in spot

21.0m lb attributable production in FY2025

Orano

Producer/fuel-cycle (France)

Competes in supply; lost Niger assets 2024

Integrated fuel cycle

Sprott Physical Uranium Trust (SPUT)

Financial buyer

Competes for spot material; price setter in spot

~2,000 tU purchased in Q1 2026

Yellow Cake plc

Financial holder

Competes for spot/term material

Holds physical U3O8

Uranium Royalty Corp

Royalty/physical holder

Physical trading counterparty/competitor

Small physical book

Independent commodity traders (e.g. Traxys, Curzon Resources)

Private traders

Direct competitors in intermediation

Financials not public

SPIC / other Chinese utilities' procurement arms

State buyers

Compete for imported material on behalf of other Chinese fleets

Financials not segmented

Peer Comparison FY2025

MetricCNNC InternationalCGN MiningCamecoKazatomprom

Revenue

HK$2.49bn (+35.2%)

HK$6.87bn (−20.3%)

n/d in sources reviewed

n/d in sources reviewed

Gross margin

10.9%1.0%——

Net margin

7.7%6.6%——

Net profit attributable

HK$192.4m

HK$452.8m

——

Volume

~8.77m lb sold (incl. facilitated)

3,315 tU sold by CGN Global (~8.6m lb, derived at 2,600 lb/tU)

21.0m lb attributable production

Production up YoY; ~10% cut planned for 2026

Equity production

—

855 tU (Semizbay-U, Ortalyk share)

21.0m lb

Largest globally

R&D intensity

0%———

Dividend

Nil

HK1.4 cents total FY2025

——

Company Snapshot

$319.6M

Revenue

39

Employees

$260M

Market Cap

2002

Founded

Wan Chai, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Net cash balance sheet: HK$907.1m cash and zero borrowings at 31 Dec 2025; HK$732.6m cash at 30 Jun 2026 (H1 2026 interim).
  • Captive, exclusive mandates: 2026 Framework Agreement (approved 10 Mar 2026) makes the group exclusive non-Asia/Africa supplier to CNUC and exclusive ex-PRC Rössing distributor through FY2027.
  • Superior trading margin vs listed peer: FY2025 gross margin 10.9% vs CGN Mining 1.0% (FY2025 results of each).
  • Strong cash conversion in FY2025: operating cash flow ~HK$288m vs net profit HK$192.4m (1.5x) (Gelonghui).
  • High returns on equity: ROE 23.1% (FY2023), 28.9% (FY2024), 22.2% (FY2025, derived).
  • Parent liquidity backstop: US$50m CNNCTM revolving facility (Jul 2024, renewed Aug 2025) plus a US$30m bank line (Jun 2026).

Weaknesses

  • Earnings volatility: H1 2026 net profit HK$5.3m vs FY2025 HK$192.4m; revenue swings of −58% (FY2021), +223% (FY2022), −36% (FY2023), +217% (FY2024), −76% (H1 2026).
  • Related-party dependence: FY2024 sales to the Parent Group (3.32m lb supply + 0.75m lb agency) dwarfed third-party principal volume (0.20m lb) (FY2024 MD&A).
  • No producing assets: Somina idle; Mongolia licences expired; E&E assets impaired to nil (FY2019).
  • No dividend despite cash: zero dividends FY2021–FY2025 and H1 2026 while holding HK$733–907m cash.
  • Thin organisation: 39 employees; admin expenses rose 21% in H1 2026 on manpower and advisory costs.
  • Governance history: 18-month trading suspension (Apr 2021–Oct 2022) after the FY2020 audit could not be completed.

Opportunities

  • Volume recovery in H2 2026: management targets ≥4m lb in H2 and ≥5m lb for FY2026 (H1 2026 interim).
  • Western demand for non-Russian supply: UK + Netherlands revenue rose to HK$648m in FY2025 from HK$8.4m in FY2024 (Gelonghui; FY2024 results).
  • Rising LT prices: ~US$95/lb in Q2 2026, a level last seen in 2008 (H1 2026 interim) — supports term-contract opportunities.
  • Acquisition of in-production assets: stated intent; balance-sheet capacity of HK$700m+ cash.
  • Mongolia re-rating: Orano's start of Zuuvch Ovoo construction (Jun 2026) improves the backdrop for resolving licence issues (H1 2026 interim).
  • Capital return: AGM general mandate to repurchase shares (Apr 2026 circular) could be used given P/B and cash levels.

Threats

  • Spot volatility from financial buyers: SPUT bought ~2,000 tU in Q1 2026, contributing to a >US$100/lb spike (H1 2026 interim).
  • Trade-policy fragmentation: US Section 232 proclamation (Jan 2026) may create divergent regional prices.
  • Niger sovereign risk: Niger revoked Orano's and other Western licences in 2024 and took control of Somaïr (FY2024 MD&A) — relevant to Somina.
  • Mandate risk: framework caps expire after FY2027 and require independent shareholder approval.
  • Interest-rate sensitivity: H1 2026 bank interest income (HK$13.4m) exceeded gross profit (HK$8.2m); lower rates would compress earnings.
  • Supply-side cost inflation: sulfuric-acid shortages (Kazakhstan; Kayelekera suspension Q2 2026) tightening available material.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 20252024 Annual Report published (FY2024 results released 25 Mar 2025: revenue HK$1.84bn, NP HK$195.0m)Sets record base; net cash HK$607m
Jun 20252025 AGM — all resolutions approvedRoutine; general mandates renewed
31 Jul 2025Positive profit alert for H1 2025 (revenue ≥HK$585m; NP ≥HK$9.5m vs loss)Signals third-party trading resumption
21 Aug 2025Announcement of up to US$50m funding for uranium trading business (parent facility)Liquidity support from CNNC
26 Aug 2025H1 2025 results: revenue HK$592.1m (vs HK$6.4m), NP HK$10.4mTurnaround; ~HK$582m from third-party sales
11 Sep 20252025 Interim Report publishedDiscloses committee composition, new company secretary
1 Dec 2025Chairman Wang Cheng retires; Li Feng appointedLeadership transition at board level
3 Dec 2025Monitor
31 Dec 20252026 Framework Agreement with CNUC announced (CCT)Renews captive business for 2026–2027
Q1 2026Spot uranium spikes above US$101/lb (first time >US$100 since Feb 2024), driven partly by SPUT buying (~2,000 tU in Q1)Triggers company's risk pullback
Jan 2026US Section 232 proclamation deems reliance on imported uranium a national-security threat; tariffs/quotas authorised for negotiationPotential Western/global price divergence
9 Feb 2026Positive profit alert for FY2025 (revenue ≥HK$2.46bn; GP ≥HK$260m; NP ≥HK$190m)Confirms core trading profit +~HK$50m
13–16 Feb 2026CCT circular and EGM noticeShareholder approval process
10 Mar 2026EGM approves 2026 Framework Agreement and annual capsRemoves renewal risk
Mar 2026China joins Declaration to Triple Nuclear Energy (38 signatories)Structural demand support
25 Mar 2026FY2025 results: revenue HK$2.49bn (+35.2%), NP HK$192.4m, EPS 39.3 cents, no dividendRecord revenue; no payout despite HK$907m cash
24 Apr 20262025 Annual Report; AGM circular (buy-back and issue mandates, director re-election, auditor reappointment)Governance
29 May 2026AGM poll resultsRoutine
3 Jun 2026Shares +7.8% intraday to HK$4.95 amid nuclear-sector rally; CNNC group investor exchange season opens 4 JunSentiment
Jun 2026US DOE conditional loan commitments of US$17.5bn for nuclear supply chain; Orano starts construction of Zuuvch Ovoo project in MongoliaContext: demand support; improved Mongolian backdrop
24 Jun 2026US$30m uncommitted bank facility signed for uranium purchasesFunding capacity for H2 volume push
3 Jul 2026Conditions precedent satisfied; Rule 13.18 disclosure of loan with specific performance covenantFacility likely tied to CNNC control
17 Jul 2026Shares −7.8% to HK$3.76Volatility ahead of H1 warning
5 Aug 2026Profit warning: H1 2026 revenue to fall by up to ~HK$451m; NP ≥HK$5mShares fell >4% on 6 Aug
6 Aug 2026Wu Ge re-designated as executive directorStrengthens executive bench
26 Aug 2026H1 2026 results: revenue HK$142.1m (−76%), NP HK$5.3m; FY2026 target ≥5m lbGuidance reset; H2-weighted year

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue rose from HKD 280.6 Mn in FY2021 to HKD 2,489.9 Mn in FY2025.
CNNC International Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue280.6905.75811,841.32,489.9
Cost of sales260802.9453.91,607.22,218.4
Gross profit20.6102.8127.1234.2271.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.